Table 1 Molecular docking results between selected ligands and Keap1.
No. | Substances | ID | Docking score | Amino acid residues |
|---|---|---|---|---|
1 | Kaempferol-3-O-(2’,6’-di-O-trans-p-coumaroyl)- β -D-glucopyranoside | 416 | − 10.4 | Ala366; Val420; Val465; Ala466; Val467; Val514; Val606 |
2 | 3″,4″-Diacetylafzelin | 720 | − 9.2 | Arg326; Ala366; Gly367; Val369; Ala466; Val514; Val606 |
3 | Kaempferol- 3-O-rutinoside | 903 | − 10.4 | Arg326; Val418; Val465; Ala466; Val512; Val514; Val561 |
4 | 1,6-digalloylglucopyranoside | 904 | − 10.4 | Gly367; Arg415; Thr560; Val561; Val604; Val606; Ala607; Val608 |
5 | Quercetin-3-O-glucopyranoside | 905 | − 9.5 | Ala366; Gly367; Val420; Ala466; Val467; |
6 | Kaempferol-3-O-rhamnoside | 718 | − 9.4 | Val420; Val465; Thr560; Val561; Val606; Val608 |
7 | β-Sitosterol-3-O-β-D-glucopyranoside | 813 | − 10.8 | Leu365; Gly367; Val418; Val512; His516; Ile559; Val561 |
8 | Niranthin | 907 | − 8.1 | Val465; Ala510; Gly558; Ile559; Val561; Thr560; Val604; Val606; Ala607 |
9 | Kaempferol-3-O-(4-O-acetyl- -L-rhamnopyranoside) | 717 | − 8.4 | Arg326; Val420; Val467; Cys513; Ile559; Thr560; Val561; Val608 |
10 | Kaempferol 3-(2″,4″-diacetylrhamnoside) | 716 | − 8.1 | Arg326; Val369; Val420; Val465; Ala466; Val467; Thr560; Val608 |
11 | Phyllanthusiin D | 911 | − 8.3 | Val514; Val561 |
12 | Stigmast-7-en-3-ol | 814 | − 9.5 | Ala366; Ala466 |
13 | Geraniin | 912 | − 12.2 | Val369; Val420; Val465; Asn469; Arg470; Val514; Val561; Val608 |
14 | Corilagin | 913 | − 11.7 | Arg326; Ala366; Val369; Ile416; Val418; Val467; Thr560; Ala607; Val608 |
15 | (-)-epicatechin 3-O-gallate | 918 | − 9.7 | Cys368; Val369; Cys513; Val514; Gly558; Ile559; Thr560; Ala607 |
16 | Rutin | 902 | − 10.3 | Arg326; Cys368; Val418; Val465; Ala466; Val512; Val514; Val561 |